Functional treatments goals

Adapted from Bridges J et al. 2018.

References
1. INVEGA^® Ministry of Health approved leaflet, 18/3/2019.
2. Risperdal^® Ministry of Health approved leaflet, 16/12/2019.
3. INVEGA SUSTENNA^® Ministry of Health approved leaflet, 18/3/2019.
4. TREVICTA^® Ministry of Health approved leaflet.19/5/2019.
5. Bridges JF, Beusterien K, Heres S, et al. Quantifying the treatment goals of people recently diagnosed with schizophrenia using best-worst scaling.
Patient Prefer Adherence. 2018;12:63-70.

CP-242855